A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer’s Disease

Table 3

The effects of the twenty-five compounds on AChE and BuChE inhibitory activities.

Compounds	AChE inhibition (%)	BuChE inhibition (%)
1	17.9 ± 0.3	37.6 ± 0.6
2	15.2 ± 0.2	28.1 ± 0.4
3	12.5 ± 0.4	75.8 ± 0.7
4	—	—
5	14.1 ± 0.3	35.3 ± 0.5
6	17.9 ± 0.2	36.0 ± 0.4
7	14.2 ± 0.5	0.6 ± 0.1
8	—	—
9	—	—
10	0.9 ± 0.1	0.1 ± 0.1
11	7.9 ± 0.3	4.0 ± 0.2
12	1.7 ± 0.2	15.1 ± 0.3
13	18.5 ± 0.4	0.5 ± 0.1
14	27.2 ± 0.2	4.2 ± 0.2
15	21.6 ± 0.4	—
16	1.1 ± 0.1	—
17	13.2 ± 0.3	—
18	15.9 ± 0.4	—
19	23.5 ± 0.4	12.3 ± 0.6
20	18.4 ± 0.4	—
21	19.2 ± 0.3	—
22	17.3 ± 0.3	—
23	20.3 ± 0.5	7.3 ± 0.2
24	21.1 ± 0.6	—
25	22.4 ± 0.2	2.8 ± 0.2
Donepezil	98.2 ± 0.8	79.8 ± 0.7